Navigation Links
Advanced Analytical Reveals New Platform for Rapid Genotypic Identification of Microorganisms at ASM 2009
Date:5/4/2009

AMES, Iowa, May 4 /PRNewswire/ -- Advanced Analytical, based in Ames, IA will reveal the latest results generated from their new instrument platform, the DNA PROfiler(TM) system. This instrument rapidly identifies microorganisms in less than 4 hours by producing a genetic fingerprint or PROfile. The generated fingerprint when compared to a database of known organisms can be used for either genus species or strain typing and tracking.

Because of its ease of use and speed, the DNA PROfiler(TM) is a game-changer in the field of genotypic identification of microorganisms. Until now, the marketplace has used biochemical-based identification systems which typically can take days to provide an answer. By comparison, the DNA PROfiler(TM) generates accurate results in under 4 hours by using 4 easy steps: DNA extraction, DNA amplification, controlled cleavage of the DNA, and multiplex CE separation of the cleaved fragments. With this multi-step technique, the DNA PROfiler(TM) combines the advantages of DNA sequencing with the advantages of Ribotyping technology. And the instrument has been put into practice, as numerous organisms from the species Candida, Mycobacterium, Staphylococcus, Salmonella, E. coli and Bacillus have been accurately identified. Advanced Analytical is currently working with the Cleveland Clinic, the US Army and other research institutes to evaluate the system for microorganism identification.

Dr. Gary Procop, Chair, Clinical Pathology, Cleveland Clinic, added; "We evaluated the differentiation of various microorganisms on a prototype instrument and compared it with other genotypic and phenotypic methods. The instrument is capable of identifying organisms quickly and easily. The implementation of such technology in the clinical laboratory should result in the faster identification of important human pathogens."

"The system has been in development for over a year now and has been tested on numerous organisms, including mycobacteria and Candida species. In all cases, the DNA PROfiler(TM) results accurately identified each organism species. There is no question that this instrument can benefit any process that needs a rapid genotype," said Dr. Steven J Lasky, CEO of Advanced Analytical.

Advanced Analytical intends to partner with companies looking for rapid, accurate genotypic identification of organisms and who are knowledgeable in the following markets: clinical and industrial microbiology, plant, animal and pharmaceutical sciences, consumer product testing and forensic testing.

About Advanced Analytical

Advanced Analytical provides innovative solutions to improve processes and accelerate research within the pharmaceutical, life science, and personal care/OTC markets. The company's product portfolio includes instruments for the rapid detection and enumeration of microbes by flow cytometry, and the parallel analysis of pharmaceutical compounds, biomolecules, proteins, DNA, RNA and carbohydrates by capillary electrophoresis with UV absorbance or fluorescence detection.

    For information: http://www.aati-us.com
    Contact: webinfo@aati-us.com
    Phone:  515-296-6600


'/>"/>
SOURCE Advanced Analytical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Technologically Advanced Digital Handheld Device Positions Network Global Logistics as Technology Leader in Last Mile Delivery Solutions
2. Prostate cancer immunotherapy significantly prolongs survival in men with advanced prostate cancer
3. Future for radioembolisation in patients with advanced hepatocellular carcinoma
4. Educating referring clinicians about advanced imaging leads to drop in imaging exams
5. Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
6. Singapore Adopts Advanced Genetic Engineering in Orthopedic Surgery
7. Millstone Medical Outsourcing Celebrates New Fall River Facility, Designed to Meet Demand for Advanced Inspection, Clean Room Services
8. Targeted Treatments Show Mettle Against Advanced Cancers
9. Drug shows activity in men with advanced prostate cancer
10. Doylestown Hospital and Perot Systems Successfully Implement Advanced MEDITECH 6.0 Platform
11. Sentillion Introduces Advanced Authentication Solution For Direct Access to Cerner, Eclipsys, Epic, McKesson and MEDITECH Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: